Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer

Table 1

Baseline characteristics of healthy controls and patients with adenomas or CRC.

	HC subjects ()	Adenomas subjects ()	CRC subjects ()	value
Gender (male/female)	38/23	19/12	49/32	N.S.^b
Age (years)	55.5; 49.5-62.5	46.9; 36-45.5	54; 47-63	N.S.^a
Total serum protein (g/dL)	66.7; 62.23-73	65.1; 62.23-70.1	68.7; 64.45-73.05	N.S.^a
Platelets (no.: 10^3/μL)	182.5; 153.5-201.8	189; 145-207.7	177; 130-209	N.S.^a
Total serum BDNF (ng/mL)	4.70; 3.52-5.67	5.97; 4.45-7.205	8.75; 5.88-10.64	<0.05

Mean standard deviation. HC: healthy control; CRC: patients with colorectal cancer; NS: nonsignificant. ^aThe Mann–Whitney test (shown as median; Q1-Q3). ^b square (shown as ).